CLINICAL_TRIALS
trial_result
· 2026-01-20
Clinical Trial Update: Venetoclax Plus CACAG Regimen for Newly Diagnosed Acute Myeloid Leukemia [Phase 2]
Summary
Phase 2 trial evaluating venetoclax in combination with the CACAG regimen for newly diagnosed acute myeloid leukemia has completed enrollment (status: completed…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chinese PLA General Hospital | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED